CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...
CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
Medical Device Network on MSN
CMR Surgical’s Versius robot secures CE mark for paediatric treatment
CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in Europe for paediatric treatment.
Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...
CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...
Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results